The significance of SIRI and SII scores in predicting the effect of omalizumab treatment in patients with severe allergic asthma
Allergologia et Immunopathologia · 2025
DOI: 10.15586/aei.v53i4.1325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2025. Verfasst von Sinem Berik Safçi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Adana City Education and Research Hospital, Chest Diseases Department Adana, Turkiye; sinemberik@hotmail.com. Hauptthemen laut MEDLINE: Omalizumab, Asthma, Anti-Asthmatic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Gefördert von: This is study was not supported by any sponsor or funder..
Abstract (Originalsprache)
Objective
To evaluate the role of systemic inflammation response index (SIRI) and systemic immune-inflammation index (SII) biomarkers in predicting the response to omalizumab (OMA) treatment in patients with severe allergic asthma.
Methods
A retrospective analysis was conducted to examine the correlation between the fourth-month treatment responses of patients undergoing OMA therapy for severe allergic asthma and their baseline neutrophil, lymphocyte, monocyte, and platelet values, as well as SIRI and SII scores.
Results
Posttreatment asthma control scores had a positive correlation with baseline SIRI (p = 0.03, r = 0.358), SII (p = 0.04, r = 0.345), and serum neutrophil values (p = 0.01, r = 0.308), and a negative correlation with lymphocyte values (p = 0.00, r = −0.398). Baseline SII showed a negative correlation with posttreatment systemic steroid usage (mg) (p = 0.04, r = −0.247) and the number of exacerbations (p = 0.02, r = −0.269).
Conclusion
SIRI and SII scores hold promise for predicting the success of OMA therapy; however, their utility needs to be validated in larger patient cohorts and further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adana City Education and Research Hospital, Chest Diseases Department Adana, Turkiye; sinemberik@hotmail.com.
- Adana City Education and Research Hospital, Chest Diseases Department Adana, Turkiye.
Förderung
- This is study was not supported by any sponsor or funder.
Zitieren
APA
Safçi, S. B., Diken, Ö. E., Kara, S., & Serintürk, T. (2025). The significance of SIRI and SII scores in predicting the effect of omalizumab treatment in patients with severe allergic asthma. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v53i4.1325
Vancouver
Safçi SB, Diken ÖE, Kara S, Serintürk T. The significance of SIRI and SII scores in predicting the effect of omalizumab treatment in patients with severe allergic asthma. Allergologia et Immunopathologia. 2025. doi:10.15586/aei.v53i4.1325
BibTeX
@article{Safi2025,
author = {Safçi, Sinem Berik and Diken, Özlem Erçen and Kara, Sibel and Serintürk, Tuğsan},
title = {The significance of SIRI and SII scores in predicting the effect of omalizumab treatment in patients with severe allergic asthma},
journal = {Allergologia et Immunopathologia},
year = {2025},
doi = {10.15586/aei.v53i4.1325}
}
EUVIMED